chr10-87864535-CT-C
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000314.8(PTEN):c.68delT(p.Leu23fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. L23L) has been classified as Likely benign.
Frequency
Consequence
NM_000314.8 frameshift
Scores
Clinical Significance
Conservation
Publications
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
 - PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
 - macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
 - renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
 - leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
 - activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Lhermitte-Duclos diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PTEN | NM_000314.8  | c.68delT | p.Leu23fs | frameshift_variant | Exon 1 of 9 | ENST00000371953.8 | NP_000305.3 | |
| PTEN | NM_001304717.5  | c.587delT | p.Leu196fs | frameshift_variant | Exon 2 of 10 | NP_001291646.4 | ||
| PTEN | NM_001304718.2  | c.-638delT | 5_prime_UTR_variant | Exon 1 of 9 | NP_001291647.1 | 
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 33 
GnomAD4 exome Cov.: 30 
GnomAD4 genome  Cov.: 33 
ClinVar
Submissions by phenotype
PTEN hamartoma tumor syndrome    Pathogenic:1 
This sequence change creates a premature translational stop signal (p.Leu23*) in the PTEN gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This particular variant has not been reported in the literature, but different changes (c.68T>G, c.68T>A) giving rise to the same protein effect (p.Leu23*) have been observed in individuals affected with Cowden syndrome (PMID: 9399897, 12938083). Loss-of-function variants in PTEN are known to be pathogenic (PMID: 9467011, 21194675). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at